Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New magnesium membrane could improve dental implant success

NCT ID NCT07526272

Disease control Sponsor: Mohamed Adel Alfeky Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new magnesium membrane against a traditional bone plate for immediate dental implants in damaged tooth sockets. Twenty-four people with failing front teeth will receive an implant and one of the two materials to support bone healing. The goal is to see which leads to better bone thickness and height, as well as nicer-looking results, over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
magnesium membrane
What this could lead to
If it works, this could offer a better way to support dental implants right after tooth extraction, potentially improving bone growth and appearance.
What could go wrong
This is a small, early-stage trial with only 24 people, so results may not apply widely. The magnesium membrane is new and could fail to perform as well as the standard bone plate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Single or multiple teeth with hopeless prognosis in maxillary anterior teeth with either type I or type II extraction sockets. * Deficient labial bone plate in width (type I) and height (type II) sockets. * Minimal of 3.0 mm basal bone present for immediate implant placement to achieve optimum primary stability. Exclusion Criteria: * Current smokers. * Patients with debilitating systemic disease. * Patients who have undergone any sort of radiotherapy and chemotherapy in past 2 years. * Pregnant and Lactating females.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Immediate dental implant in type 2 extraction socket are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Immediate dental implant in type 2 extraction socket Vestibular socket therapy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Misr University for Science and Technology

    RECRUITING

    Giza, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.